Search results
Results From The WOW.Com Content Network
United States v. Riverside Bayview, 474 U.S. 121 (1985), was a United States Supreme Court case challenging the scope of federal regulatory powers over waterways as pertaining to the definition of "waters of the United States" as written in the Clean Water Act of 1972.
Protection of wetlands and small streams is a major focus of the Clean Water Rule. The Clean Water Rule is a 2015 regulation published by the U.S. Environmental Protection Agency (EPA) and the United States Army Corps of Engineers (USACE) to clarify water resource management in the United States under a provision of the Clean Water Act of 1972. [1]
By interpreting the scope of "waters of the United States" as used in section 404, SWANCC will affect the scope of other CWA sections whose jurisdictional scope is defined by that same phrase. Such sections include those governing oil spill cleanup (section 311), the National Pollutant Discharge Elimination System permit program (section 402 ...
Stephen Bullock’s phone rang early Monday morning last week at his small factory in North Carolina with an urgent message from his distributor up in Toronto who was rattled by what looked like ...
Litton Industries, Inc., was an American defense contractor that specialized in shipbuilding, aerospace, electronic components, and information technology. The company was founded in 1953 and was named after inventor Charles Litton Sr., who was also an early investor in the company.
Image source: The Motley Fool. Vici Properties (NYSE: VICI) Q4 2024 Earnings Call Feb 21, 2025, 10:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Riverside Bayview, the unanimous Court had found that wetlands abutting Lake St. Clair were included in the Corps's jurisdiction over waters of the United States. [12] In 2001, a divided Court found that the migratory bird rule could not reach isolated ponds in Solid Waste Agency of Northern Cook County v. Army Corps of Engineers (SWANCC). [13]
GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably heard of them under brand names like Ozempi c® and Wegovy ...